"Geron Announces Plans for Imetelstat Phase 3 Clinical Trial in Myelofibrosis and Other Updates"
about Geron Corporation
Notified: 16:01 EDT at $2.15
"Amarin Supports Trial to Investigate the Effects of VASCEPA® (icosapent ethyl) in the Treatment of COVID-19"
about Amarin Corporation plc
Notified: 16:05 EDT at $7.87
"PDL BioPharma Completes Distribution of Evofem Biosciences Common Stock to PDL Stockholders"
about Evofem Biosciences, Inc.
Notified: 16:06 EDT at $4.83
"Navidea Biopharmaceuticals Announces Positive Results of Second Interim Analysis of Ongoing Phase 2B Study in Rheumatoid Arthritis"
about Navidea Biopharmaceutical..
Notified: 16:31 EDT at $1.85
"ECOG-ACRIN Provides Syndax Pharmaceuticals With Results of Phase 3 E2112 Trial of Entinostat Plus Exemestane in Patients with HR+, HER2- Bre..."
about Syndax Pharmaceuticals, I..
Notified: 16:36 EDT at $20.50
"AMAG Pharmaceuticals Completes Sale of its Rights to Intrarosa® to Millicent Pharma for up to $125 Million"
about AMAG Pharmaceuticals, Inc..
Notified: 17:00 EDT at $7.47
"Option Care Health Selected as Preferred Pharmacy Partner To Prepare and Distribute Breakthrough Cancer Therapy"
about Option Care Health, Inc.
Notified: 17:00 EDT at $13.96
"Aquestive Therapeutics Advances Royalty Monetization Plan as Sunovion Pharmaceuticals’ Apomorphine Sublingual Film Therapy Receives FDA Appr..."
about Aquestive Therapeutics, I..
Notified: 17:26 EDT at $6.22
"Tetraphase Announces Determination of Superior Offer and Notice to AcelRx"
about AcelRx Pharmaceuticals, I..
Notified: 21:55 EDT at $1.53
"iQIYI Partners with MediaTek to Provide AV1-powered Ultra HD Streaming Experience in 5G Era"
about iQIYI, Inc.
Notified: 07:22 EDT at $15.77
"Daxor’s BVA-100® Published in Novel Study in American Heart Association Journal - Circulation"
about Daxor Corp.
Notified: 08:01 EDT at $14.25
"Xeris Pharmaceuticals Announces Positive Findings From the Outpatient Portion of a Phase 2 Proof-of-Concept Study of Its Developmental Ready..."
about Xeris Pharmaceuticals, In..
Notified: 08:01 EDT at $4.70
"Nektar Therapeutics Announces Publication of Results from Phase 1 Dose-Escalation Study for Bempegaldesleukin Plus Nivolumab in 'Cancer Disc..."
about Nektar Therapeutics
Notified: 08:31 EDT at $22.30
"XpresSpa Signs Contract with JFK International Air Terminal LLC for COVID-19 Screening and Testing Location"
about XpresSpa Group, Inc.
Notified: 09:01 EDT at $0.64
"Orgenesis Announces Collaboration with Hospital Infantil Universitario Niño Jesús, Madrid, to Establish Point of Care Center"
about Orgenesis Inc.
Notified: 09:11 EDT at $7.55
Notice: Price change for each notified stock are being tracked by Preticks after signal notification and given stock price change analysis in this daily summary is being calculated accordingly. You can explore details for each notified signal in daily detailed performance analysis page.